Pyridopyrimidinone inhibitors of PI3Kα and mTOR
US8101622B2 · kind B2 · utility
6Cited by
1References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 29, 2009 |
| Grant date | Jan 24, 2012 |
| Priority date | — |
| Expiry date | Sep 29, 2029 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention is directed to Compounds of Formula I:optionally as a single stereoisomer or mixture of stereoisomers thereof, and additionally optionally as a pharmaceutically acceptable salt thereof; as well as methods of making and using the compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.